chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Abdominal pain upper, Fatigue, Papule, Pyrexia, Scar
Clinical narrative: Information has been received from a consumer concerning her 5 year old son with predisposition to autism, methylenetetrahydrofolate reductase deficiency (MTHFR), "1968-C", allergy to milk as a baby and betamethasone (also reported as bethamethosone) allergy and a history of an unknown virus on 25-JUN-2010 (during 4 days) that on 26-JUN-2010 was treated with ROCEPHIN because they thought it was strep throat, but it was not. He became fever free four days later, so before he got the VARIVAX shot he was fever free. On 02-JUL-2010, the patient was vaccinated SQ with a 0.5 ml dose of VARIVAX (Merck) (Lot# unknown). There was no concomitant medication. The consumer reported that on 04-JUL-2010, the patient got the symptoms of chicken pox. On the night of 14-JUL-2010, he started to get a fever. His temperature went up to 105 degrees. On 15-JUL-2010, the spots started to appear. There were two on his back, and one on his stomach by the rib. On 16-JUL-2010, they went to the doctor, who diagnosed it as chickenpox caused by the VARIVAX (Merck). On 16-JUL-2010, when they went to the doctor, he had 18 spots, but they did not have blisters. He was scratching them so they started scarring. The total number of spots he got was 30. On 19-JUL-2010, he was well with no fever. The spots took about a week to heal up. There were still 3 spots on his body that appeared as scars. On an unspecified date a "strep culture" was performed (results not provided). Follow up information has been received from a physician who indicated that the patient on 02-JUL-2010 was vaccinated with a first dose of VARIVAX (Merck) (lot# 666368/0227Z). On 15-JUL-2010, 13 days after immunization, the patient developed fever 102, fatigue, stomach ache and papules on chest. Subsequently, the patient recovered. Follow up information was received from a consumer concerning her son who had "31 pox" after receiving the first dose of VARIVAX last year on 02-JUL-2010 (Lot # 666368/0227Z, expire date not reported), 0.5 ml, subcutaneously. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Scratch, Streptococcus test, Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her 5 year old son with predisposition to autism, methylenetetrahydrofolate reductase deficiency (MTHFR), "1968-C", allergy to milk as a baby and betamethasone (also reported as bethamethosone) allergy and a history of an unknown virus on 25-JUN-2010 (during 4 days) that on 26-JUN-2010 was treated with ROCEPHIN because they thought it was strep throat, but it was not. He became fever free four days later, so before he got the VARIVAX shot he was fever free. On 02-JUL-2010, the patient was vaccinated SQ with a 0.5 ml dose of VARIVAX (Merck) (Lot# unknown). There was no concomitant medication. The consumer reported that on 04-JUL-2010, the patient got the symptoms of chicken pox. On the night of 14-JUL-2010, he started to get a fever. His temperature went up to 105 degrees. On 15-JUL-2010, the spots started to appear. There were two on his back, and one on his stomach by the rib. On 16-JUL-2010, they went to the doctor, who diagnosed it as chickenpox caused by the VARIVAX (Merck). On 16-JUL-2010, when they went to the doctor, he had 18 spots, but they did not have blisters. He was scratching them so they started scarring. The total number of spots he got was 30. On 19-JUL-2010, he was well with no fever. The spots took about a week to heal up. There were still 3 spots on his body that appeared as scars. On an unspecified date a "strep culture" was performed (results not provided). Follow up information has been received from a physician who indicated that the patient on 02-JUL-2010 was vaccinated with a first dose of VARIVAX (Merck) (lot# 666368/0227Z). On 15-JUL-2010, 13 days after immunization, the patient developed fever 102, fatigue, stomach ache and papules on chest. Subsequently, the patient recovered. Follow up information was received from a consumer concerning her son who had "31 pox" after receiving the first dose of VARIVAX last year on 02-JUL-2010 (Lot # 666368/0227Z, expire date not reported), 0.5 ml, subcutaneously. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Cellulitis, Injection site erythema, Oedema peripheral
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an 11 year old female patient with asthma, allergic rhinitis and allergy to amoxicillin and latex who on 06-AUG-2010 was vaccinated subcutaneously with a 0.5mL dose of VARIVAX (Merck) (Lot number 666920/0547Z) (Expiration date: 08-APR-2012). Concomitant therapy included albuterol inhaler, XOPENEX and PULMICORT in nebulizer. The nurse reported that on 07-AUG-2010 the patient called to report that the injection site was reddened 3.5 inches in diameter. On 07-AUG-2010, the patient's mother called to report that patient's arm was swollen and had doubled in size. Patient was afebrile at that time. Patient was taken to the emergency room where she was examined by a physician who diagnosed the patient with cellulitis. Patient was hospitalized and put on an antibiotic and sent home. At the time of report, the patient was recovering. Follow-up information has been received from the registered nurse, concerning the 11 year old female patient who on 06-AUG-2010 was vaccinated subcutaneously with a 0.5mL dose of VARIVAX (Merck) (Lot number 666920/0547Z) (Expiration date: 08-APR-2010). Concomitant therapy also included MENACTRA (Lot # U3460BA). The nurse reported on 07-AUG-2010 that the patient's mother called to report that the patient had a 3.5 centimeter red mark on her left arm. On 08-AUG-2010 the mother called the nurse and took the patient to the emergency room. The patient was diagnosed with cellulitis. Nurse reported that the patient was not admitted to the hospital. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: DTAP, FLU3, MMR, VARCEL
Symptoms: Abasia, Blister, Herpes zoster, Injection site dryness, Injection site rash
Clinical narrative: Information has been received from a physician concerning a 15 month old male patient who in November 2010, was vaccinated with a dose of VARIVAX (Merck) (dose, route and Lot# not reported). The physician stated that on 07-FEB-2011 the patient experienced rash on his leg and would not walk shortly after receiving VARIVAX (Merck). Patient was given acyclovir as a treatment. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Follow-up information was received from a licensed practical nurse concerning an 18 month old male patient (previously reported as 15 month old by physician) with "strep" at the time of vaccination who on 04-NOV-2010 was vaccinated with the first dose of VARIVAX (Merck (Lot # 667490/0784Z, expire date not reported), subcutaneously in the left thigh and with the first dose of MMR II (Lot # 667731/0647Z, expire date not reported), subcutaneously in the left thigh. Concomitant therapy included the fourth dose of DAPTACEL (lot # C3381AA, expire date not reported), intramuscularly in the right thigh and the first dose of FLUZONE (lot # LT3639AA, expire date not reported), intramuscularly in the right thigh, administered also on 04-NOV-2010. Licensed practical nurse stated that on 09-FEB-2011, the patient could not walk and developed blisters on his left thigh and his privates. The patient was diagnosed with shingles and treated with acyclovir 200/5 3.25 ml TID for 7 days. On 17-FEB-2011, they called to the patient's home to have him come in after training with vaccines. Licensed practical nurse stated that the site was dry with no scabs; so none was collected to try to get viral culture. On 17-FEB-2011, the patient recovered. The patient did not seek medical attention. Attention information is not expected.
Age: 1.25
Sex: M
Vaccine: DTAP, FLU3, MMR, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Information has been received from a physician concerning a 15 month old male patient who in November 2010, was vaccinated with a dose of VARIVAX (Merck) (dose, route and Lot# not reported). The physician stated that on 07-FEB-2011 the patient experienced rash on his leg and would not walk shortly after receiving VARIVAX (Merck). Patient was given acyclovir as a treatment. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Follow-up information was received from a licensed practical nurse concerning an 18 month old male patient (previously reported as 15 month old by physician) with "strep" at the time of vaccination who on 04-NOV-2010 was vaccinated with the first dose of VARIVAX (Merck (Lot # 667490/0784Z, expire date not reported), subcutaneously in the left thigh and with the first dose of MMR II (Lot # 667731/0647Z, expire date not reported), subcutaneously in the left thigh. Concomitant therapy included the fourth dose of DAPTACEL (lot # C3381AA, expire date not reported), intramuscularly in the right thigh and the first dose of FLUZONE (lot # LT3639AA, expire date not reported), intramuscularly in the right thigh, administered also on 04-NOV-2010. Licensed practical nurse stated that on 09-FEB-2011, the patient could not walk and developed blisters on his left thigh and his privates. The patient was diagnosed with shingles and treated with acyclovir 200/5 3.25 ml TID for 7 days. On 17-FEB-2011, they called to the patient's home to have him come in after training with vaccines. Licensed practical nurse stated that the site was dry with no scabs; so none was collected to try to get viral culture. On 17-FEB-2011, the patient recovered. The patient did not seek medical attention. Attention information is not expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received which reported that a 24 month old male who on 02-FEB-2011 was vaccinated with a dose of VARIVAX (Merck) (therapy route and lot # not provided). On 14-FEB-2011 the patient experienced vesicular rash while on therapy with VARIVAX (Merck). Patient sought unspecified medical attention. At the time of reporting, the patient had recovered. Additional information has been requested.
Age: 0.9
Sex: M
Vaccine: HEPA, MMR, PPV, VARCEL
Symptoms: Ear discomfort, Rash erythematous, Rash papular, Respiratory tract congestion, Vomiting
Clinical narrative: Information has been received from a registered nurse concerning a 11 month old male patient with a history of viral induced neutropenia who on 03-FEB-2011 was vaccinated with a dose of VARIVAX (Merck) (Lot # 667980/1102Z, expire date and route not reported). Suspect therapy included a dose of MMR II (Lot #, expire date and route not reported), and VAQTA (Lot #, expire date and route not reported), and PNEUMOVAX 23 (manufacturer unknown, lot #, expire date and route not reported), administered on the same day. Registered nurse stated that on 14-FEB-2011, the patient experienced congestion, "pulling at his ears" vomiting and red papular rash on abdomen and back. No treatment was given to the patient. The patient did not seek medical attention. At the time of the report, patient's outcome was unknown. Registered nurse requested the VZIP test packet. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test, Varicella post vaccine
Clinical narrative: Information has been received from a registered pharmacist (also reported received by the physician) concerning her daughter who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) SQ. Subsequently, 8 or 9 years later got a breakthrough case of the chicken pox. Titers were checked (results were not provided). At the time of reporting, the patient's outcome was unknown. It was unspecified if the patient sought medical attention. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Scab, Skin lesion
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male patient who on 22-JUN-2010, was subcutaneously vaccinated in the left arm with the first dose of VARIVAX (Merck) (Lot# 665900/1604Y), at 9:40 AM. It was reported that on 05-JUL-2010, the patient developed red lesion on the right hand that crusted over and also had few red lesions in diaper area. The patient did not have fever and was acting well. Subsequently, on an unspecified date, the patient recovered. No further information is available.
Age: 13.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Decreased appetite, Dizziness, Dry throat, Fatigue, Hyperhidrosis
Clinical narrative: Information has been received from a master of public health concerning her 13 year old son with seasonal allergy and a history of born premature 36 weeks who on 06-JUL-2010 was vaccinated subcutaneously with a booster 0.5ml dose of VARIVAX (Merck) (lot# 666369/0226Z) and a booster 0.5ml dose of VAQTA (lot# 667932/0568Z) IM into the left arm because he was going to another country and needed booster for the above two vaccines. Other concomitant therapy included ZYRTEC. It was reported that the patient received the first dose of VARIVAX (Merck) (lot# not reported) when the vaccine first came out and in 2004 or 2005 he had a mild outbreak of chickenpox. On 08-JUL-2010 the patient developed a dry throat and hamstrings and quads of both legs hurting. The mother thought it was due to her son playing baseball and football. On 09-JUL-2010, in the morning, the patient developed sore throat, loss of appetite, fever of 100.2F, sweating, felt nauseous and lightheaded when stood up but when laid down was fine. On 09-JUL-2010, at 8:30, the patient went to the physician's office, and the fever was down to 99F and the patient was feeling better. There were no laboratory diagnostics studies performed. At the time of this report, the patient's legs were still achy and unknown if his appetite had come back. Follow up information has been received from a registered nurse concerning the 13 year old male student who on 06-JUL-2010, at 12:05, was vaccinated with the second dose of VAQTA (lot# 667932/0568Z) IM into the left arm; at 12:09, he was vaccinated with the second dose of VARIVAX (Merck) (lot# 666369/0226Z) SQ into the left arm. There was no illness at time of vaccination. On 08-JUL-2010, the patient developed fever of 99.5F, fatigue, body aches, sore throat and possible viral illness. The patient received no treatment except fever reducer and pain reliever. On 10-JUL-2010, the patient recovered. Additional information is not expected.
Age: 13.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Myalgia, Nausea, Oropharyngeal pain, Pain, Pain in extremity
Clinical narrative: Information has been received from a master of public health concerning her 13 year old son with seasonal allergy and a history of born premature 36 weeks who on 06-JUL-2010 was vaccinated subcutaneously with a booster 0.5ml dose of VARIVAX (Merck) (lot# 666369/0226Z) and a booster 0.5ml dose of VAQTA (lot# 667932/0568Z) IM into the left arm because he was going to another country and needed booster for the above two vaccines. Other concomitant therapy included ZYRTEC. It was reported that the patient received the first dose of VARIVAX (Merck) (lot# not reported) when the vaccine first came out and in 2004 or 2005 he had a mild outbreak of chickenpox. On 08-JUL-2010 the patient developed a dry throat and hamstrings and quads of both legs hurting. The mother thought it was due to her son playing baseball and football. On 09-JUL-2010, in the morning, the patient developed sore throat, loss of appetite, fever of 100.2F, sweating, felt nauseous and lightheaded when stood up but when laid down was fine. On 09-JUL-2010, at 8:30, the patient went to the physician's office, and the fever was down to 99F and the patient was feeling better. There were no laboratory diagnostics studies performed. At the time of this report, the patient's legs were still achy and unknown if his appetite had come back. Follow up information has been received from a registered nurse concerning the 13 year old male student who on 06-JUL-2010, at 12:05, was vaccinated with the second dose of VAQTA (lot# 667932/0568Z) IM into the left arm; at 12:09, he was vaccinated with the second dose of VARIVAX (Merck) (lot# 666369/0226Z) SQ into the left arm. There was no illness at time of vaccination. On 08-JUL-2010, the patient developed fever of 99.5F, fatigue, body aches, sore throat and possible viral illness. The patient received no treatment except fever reducer and pain reliever. On 10-JUL-2010, the patient recovered. Additional information is not expected.
Age: 13.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Pyrexia
Clinical narrative: Information has been received from a master of public health concerning her 13 year old son with seasonal allergy and a history of born premature 36 weeks who on 06-JUL-2010 was vaccinated subcutaneously with a booster 0.5ml dose of VARIVAX (Merck) (lot# 666369/0226Z) and a booster 0.5ml dose of VAQTA (lot# 667932/0568Z) IM into the left arm because he was going to another country and needed booster for the above two vaccines. Other concomitant therapy included ZYRTEC. It was reported that the patient received the first dose of VARIVAX (Merck) (lot# not reported) when the vaccine first came out and in 2004 or 2005 he had a mild outbreak of chickenpox. On 08-JUL-2010 the patient developed a dry throat and hamstrings and quads of both legs hurting. The mother thought it was due to her son playing baseball and football. On 09-JUL-2010, in the morning, the patient developed sore throat, loss of appetite, fever of 100.2F, sweating, felt nauseous and lightheaded when stood up but when laid down was fine. On 09-JUL-2010, at 8:30, the patient went to the physician's office, and the fever was down to 99F and the patient was feeling better. There were no laboratory diagnostics studies performed. At the time of this report, the patient's legs were still achy and unknown if his appetite had come back. Follow up information has been received from a registered nurse concerning the 13 year old male student who on 06-JUL-2010, at 12:05, was vaccinated with the second dose of VAQTA (lot# 667932/0568Z) IM into the left arm; at 12:09, he was vaccinated with the second dose of VARIVAX (Merck) (lot# 666369/0226Z) SQ into the left arm. There was no illness at time of vaccination. On 08-JUL-2010, the patient developed fever of 99.5F, fatigue, body aches, sore throat and possible viral illness. The patient received no treatment except fever reducer and pain reliever. On 10-JUL-2010, the patient recovered. Additional information is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Scab, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a female patient who in 1994 (the licensure date of VARIVAX (Merck) was in spring of 1995), was vaccinated with a dose of VARIVAX (Merck). In March 2010, the patient experienced contracted chickenpox. Her case was full-blown with a significant number of vesicles that scabbed in the classic manner. It is unknown if the patient sought medical attention. At the time of the report, the outcome of the patient was unknown. The physician questioned whether the patient actually received the vaccine but that the parent had merely given a fictitious date. Possibly there was no vaccine ever given. It was also reported that the patient's sister experienced chickenpox after receiving VARIVAX (Merck) (WAES# 1004USA01684). Additional information is not expected.
Age: 1.03
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 4 year old male patient with no pertinent medical history, drug reactions or allergies who on 29-NOV-1999 was vaccinated with a dose of VARIVAX (Merck) (Lot# unknown). There was no concomitant medication. The nurse reported that "about 3 years later when the patient was 4 years old" in approximately 2002, the patient developed shingles. The patient recovered "when he was 4 years old" in approximately 2002. The patient is now 11 years old. The patient sought unspecified medical attention. Follow up information has been received from a nurse practitioner concerning the currently 11 year old male student who on 29-NOV-1999 was vaccinated with a dose of VARIVAX (Merck) at another office. There was no illness at time of vaccination. The nurse practitioner reported that the patient did not have adverse reaction to vaccine. He had a diagnosed/confirmed case of shingles at age of 4. She called to see if patient needed a second dose of VARIVAX (Merck). Additional information is not expected.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Blood human chorionic gonadotropin positive, Drug exposure during pregnancy, Pyrexia
Clinical narrative: Information has been received from a consumer for VARIVAX (Merck), a Pregnancy Registry product, concerning her 17 year old son's girlfriend with no known allergies who on 14-MAY-2010 was vaccinated with a first dose of VARIVAX (Merck) (lot number not provided). There was no concomitant medication. On 19-MAY-2010 the patient developed a fever of 104 degrees Fahrenheit and she was taken to the emergency room. On 19-MAY-2010, she received TYLENOL for the fever and she had a positive pregnancy test which showed she was currently four weeks pregnant. Last menstrual period was approximately on 10-SEP-1992. On 12-JUL-2010, the girl's mother took her to the clinic for her second dose of VARIVAX (Merck). On 12-JUL-2010, the person administering the injection did not ask if she was pregnant and the patient received the second dose of VARIVAX (Merck) (lot number not provided). No other relevant laboratory testing was performed. The consumer reported that on 12-JUL-2010 the patient would not be receiving any more doses of VARIVAX (Merck). Estimated delivery date is approximately on 26-JAN-2011. At the time of the report the patient was currently "feeling fine". It was unspecified if the patient sought medical attention. Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Headache, Musculoskeletal stiffness, Papule, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 49 year old female with no medical history or allergies who on 06-JUL-2010 was vaccinated SQ with the first 0.5 ml dose of VARIVAX (Merck) (lot # 665642/1457Y). Concomitant therapy included PETADOLEX, MIGRANAL, MIGRE-LIEF and alendronate sodium. On 10-JUL-2010 the patient experienced generalized rash, headache, stiffness of neck, slight fever, but no cough. The rash was on the face, torso, arms and back that was generalized eruption compatible with varicella with some vesicles and some without vesicles. There was lesion on the soft palate in the mouth (flat red lesion). The patient had a full case of chickenpox. There were no laboratory studies performed. The patient had an office visit to seek medical attention. At the time of report, the patient was recovering. Nurse also mentioned that the patient's husband had shingles but her husband was recovered prior to the patient getting VARIVAX (Merck). In follow-up, the nurse indicated that the VARIVAX (Merck) was administered into the left arm. On 10-JUL-2010 the patient contacted the doctor complaining of generalized rash and lesions, some with papules, some flat on face, neck, torso, and soft palate. The patient also complained of headache, mild stiff neck and low fever. On an unspecified date in 2010 the patient recovered from the events. Additional information is not expected.
Age: 49.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Skin lesion, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 49 year old female with no medical history or allergies who on 06-JUL-2010 was vaccinated SQ with the first 0.5 ml dose of VARIVAX (Merck) (lot # 665642/1457Y). Concomitant therapy included PETADOLEX, MIGRANAL, MIGRE-LIEF and alendronate sodium. On 10-JUL-2010 the patient experienced generalized rash, headache, stiffness of neck, slight fever, but no cough. The rash was on the face, torso, arms and back that was generalized eruption compatible with varicella with some vesicles and some without vesicles. There was lesion on the soft palate in the mouth (flat red lesion). The patient had a full case of chickenpox. There were no laboratory studies performed. The patient had an office visit to seek medical attention. At the time of report, the patient was recovering. Nurse also mentioned that the patient's husband had shingles but her husband was recovered prior to the patient getting VARIVAX (Merck). In follow-up, the nurse indicated that the VARIVAX (Merck) was administered into the left arm. On 10-JUL-2010 the patient contacted the doctor complaining of generalized rash and lesions, some with papules, some flat on face, neck, torso, and soft palate. The patient also complained of headache, mild stiff neck and low fever. On an unspecified date in 2010 the patient recovered from the events. Additional information is not expected.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Oropharyngeal pain, Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 17 year old female with no routine medications, no medical history and no known allergies who on 12-MAR-1996 was vaccinated with the first dose of VARIVAX (Merck) (Lot# 608586/0413B, therapy dose, route and site unknown) and on 18-OCT-2007 received the second dose of VARIVAX (Merck) (Lot# 658572/1257U, therapy dose, route and site unknown). On 10-JUL-2010 the patient was seen in the office with chicken box with dried lesions and a sore throat which had started on 06-JUL-2010. The patient was treated with acetaminophen. At the time of this report, the patient was doing better. This is one of several reports received from the same source. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Rash
Clinical narrative: Information has been received from a licensed practical nurse concerning a 15 year old female patient with no pertinent medical history and no known drug allergies who in 2003 was vaccinated with the first dose of VARIVAX (Merck) (Lot # 645048/0197N, expire date and route not reported). On 17-FEB-2011, the patient was vaccinated with the second dose of VARIVAX (Merck) (Lot #, expire date and route not reported). There was no concomitant medication. Licensed practical nurse stated that a few years after administration of one dose of VARIVAX (Merck) on 16-FEB-2010, the patient developed shingles of the right side of her face. On 16-FEB-2010 and on 27-FEB-2010, the patient was examined by physician. Licensed practical nurse mentioned that on 27-FEB-2010, patient's rash was worse. Patient was given VALTEX for 2 weeks. There were no laboratory diagnostics studies performed. On an unspecified date, the patient recovered. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: DTAP, FLU3, MMR, VARCEL
Symptoms: Abasia, Herpes zoster, Injection site rash, Skin lesion
Clinical narrative: Information has been received from a medical assistant concerning an 18 month old male patient with no pertinent medical history and no drug reactions or allergies who on 04-NOV-2010 was vaccinated with the first dose of VARIVAX (Merck) (Lot # 667490/0784Z, expire date 15-JUL-2012, 0.5 ml, subcutaneously in the left thigh. Suspect therapy administered on the same day included MMR II (Lot #, expire date and route not reported), in the left thigh. Concomitant therapy included DTaP, in the right thigh, and FLUZONE, in the right thigh, both administered on the same day. Medical assistant stated that on 09-FEB-2011, child presented to doctor office and was not able to walk. When child's pant leg was pulled up he had lesions on left leg at thigh; child had shingles. Child was treated with acyclovir. Medical assistant mentioned that on follow up visit on 17-FEB-2011, the lesions were all dried up. Medical assistant stated that "it looked awesome, child totally recovered". There were no laboratory diagnostics studies performed. Additional information has been requested.
Age: 3.0
Sex: U
Vaccine: VARCEL
Symptoms: Blister, Erythema, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 36 month old patient who on 18-FEB-2011 was vaccinated with a dose of VARIVAX (Merck) (Lot #, expire date and route not reported). Physician stated that on 19-FEB-2011 after receiving VARIVAX (Merck), the patient experienced fever and on 20-FEB-2011 the patient experienced "white blisters with red centers". The patient sought medical attention by phone call. At the time of the report, patient's outcome was unknown. Additional information has been requested.
Age: 67.0
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a 67 year old male patient who on 18-FEB-2011 was inadvertently vaccinated SQ with a 0.5ml dose of VARIVAX (Merck) (lot number not provided), when he was intended to receive ZOSTAVAX (Merck). No adverse symptoms were reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site reaction
Clinical narrative: Information has been received from a physician concerning a patient who in January 2011, was vaccinated with the first dose of VARIVAX (Merck) (lot # not reported). In January 2011, the patient experienced an injection site reaction. At the time of reporting, the outcome of the patient was unknown. It was unknown if the patient sought medical attention. Additional information is not expected.
Age: 1.7
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Pain, Rash
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 20 month old female patient who in approximately September 2010 ("12-15 months of age"), was vaccinated with VARIVAX (Merck) (lot # not reported). On 31-JAN-2011 the patient was seen in the office presenting with a rash on her legs that looked like insect bites. On 02-FEB-2011 the patient was seen in the office again with classic shingles on her right leg. The patient experienced significant pain from the shingles. ZOVIRAX was given to the patient for treatment of the adverse event. On 10-FEB-2011 the patient was seen in the office and was better. The patient's mother was 33 weeks pregnant. The mother had natural chicken pox as a child and shingles when she was young. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning his daughter (child) who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (lot # not reported). Subsequently the patient developed chicken pox. The patient had sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Papule, Rash, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a first 0.5 ml dose of VARIVAX (Merck) (therapy route and lot # not provided). The reporter stated that the patient came into her office" today", on 24-FEB-2011 who had developed chicken pox, even though the patient had been given VARIVAX (Merck) in the past. At the time of reporting, the patient's status was not provided. The patient sought unspecified medical attention. This is one of several reports received from the same source. Follow up information has been received from a medical assistant concerning the 4 year old male with asthma and rhinitis allergic and a history of respiratory syncytial virus infection and pneumonia who on 04-JAN-2008 was vaccinated with the first dose of VARIVAX (Merck) (lot# 658937/1560U) subcutaneously in the left thigh. On 02-JUL-2010 the patient was vaccinated with the second dose of VARIVAX (Merck) (lot # 665900/1604Y) in the right deltoid. On 04-JAN-2008, the patient was also received the third dose of (DAPTACEL) (Sanofi) (lot # C2800AA) in the left thigh, and the fourth dose of PREVNAR (lot # B47300H) in the right thigh, which was given elsewhere. Secondary suspect therapy included the second dose of MMR II (lot# 665803/1290Y) in the left deltoid on 02-JUL-2010. On 06-MAR-2011, the patient developed rash, no fever and multiple papules in different stages, over upper, lower extremities, lower abdomen and face and was diagnosed with varicella. The patient sought medical attention via doctor visit. OTC BENADRYL was given for treatment. At the time of reporting, the status of the patient was unknown. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning his son (child) who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (lot # not reported). Subsequently the patient developed chicken pox. The patient had sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a second 0.5 ml dose of VARIVAX (Merck) (therapy route and lot # not provided). The reporter stated that the patient came into her office "today", on 24-FEB-2011 who had developed chicken pox, even though the patient had been given VARIVAX (Merck) in the past. At the time of reporting, the patient's status was not provided. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse practitioner concerning a 11 year old female patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (lot number not provided), at school. Concomitant therapy included Tdap (manufacturer unspecified). The nurse stated that on 25-FEB-2011 the patient came to see her due to an injection site reaction of cellulitis. The patient sought unspecified medical attention. It was unspecified if any treatment was given or any lab diagnostic studies were performed. At the time of the report the patient's outcome was unknown. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: FLU3, MEN, VARCEL
Symptoms: Head injury, Syncope
Clinical narrative: Information has been received from a registered nurse concerning a 12 year old male patient, who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (Lot # not reported). Secondary suspect therapy included AFLURIA (manufacturer unknown). Concomitant therapy included meningococcal vaccine (unspecified). The nurse reported that the patient fainted after receiving all three vaccines and a blood drawn (results not provided). The patient hit his head as he was fainting and was sent to emergency room. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a nurse practitioner concerning her 5 year and 6 month old niece who on 17-DEC-2010 was vaccinated with the second dose of VARIVAX (Merck) (Lot #, expire date and route not reported), 0.5 ml. Nurse practitioner reported that two months and a week after her niece completed her therapy with VARIVAX (Merck) on approximately 24-FEB-2011, her niece developed a shingles type rash on her chest. The patient was then taken to a pediatrician's office and it was confirmed that she had shingles. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: UNK, VARCEL
Symptoms: Injection site erythema
Clinical narrative: Information has been received from an office manager and a consumer concerning her 5 year old son who on approximately October 2006, 06-JAN-2011 and 24-FEB-2011 was vaccinated respectively with the first, second and third (0.5ml) doses of VARIVAX (Merck) (lot numbers not provided). The consumer reported that on 24-FEB-2011 the patient received 3 vaccinations the day the third dose of VARIVAX (Merck) was administered (two in one arm and one in the other arm) and the patient developed a red ring at the injection site on one arm. The red ring was described as 2 inches around. It was unknown which vaccines were administered at the injection site that developed the red ring. The names of the other vaccines were unspecified. It was unspecified if the patient sought medical attention, if any lab diagnostic studies were performed or if any treatment was given for the adverse event. It was reported that the red ring cleared up after a couple of days. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from an allergist physician concerning a child patient (also reported as "I believe it was a boy"), who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (Lot # not reported). The physician reported that the patient broke out in a rash after taking VARIVAX (Merck). The patient had been seen in touch with medical services. The physician thought it could be that the patient was allergic to one or some of the preservatives in the vaccine. The child got the vaccine at a pediatrician's office. The physician was not sure if they tested the patient for this, but the patient could be allergic to these preservatives gelatin and neomycin. The physician did not think the child had had another shot because of the reaction. No further information is available.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pruritus
Clinical narrative: Information has been received from a female consumer who on an unspecified date was vaccinated with a dose of VARIVAX (dose not reported). The consumer stated she experienced "itchiness" at the site of VARIVAX. It was unspecified if the patient sought medical attention. At the time of reporting the patient outcome was unspecified. No further information is available.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Mass, Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning a 7 years old female with penicillin allergy and medical history of dermatitis atopic in 2009. Who on 18-MAY-2005, was vaccinated with VARIVAX (Merck), first dose (lot # 648315/0072R expiration date January 2007). On 29-OCT-2008, patient received the second dose of VARIVAX (Merck) (Lot# 661666/1192X expiration date 20-AUG-2010) 0.5 ml subcutaneously. There was no concomitant medication. On approximately 26-FEB-2011, the patient started with pink bump that turned into a lesion. The areas affected were chest, face and arms. The patient was seen in the office on 01-MAR-2011 and diagnosed with chicken pox. No labs or tests were done. No treatment given for the adverse event. At the time of the report, the patient still had lesions (lesions were not crusting over or scabbing over but not blistering). Also, a licensed practical nurse mentioned that the patient's mother told her there were two other children on the block that had similar rashes, and one child had seen their physician and the other child will be seeing their physician. Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: VARCEL
Symptoms: Neuralgia, Rash
Clinical narrative: Information has been received from a physician concerning a 52 year old female with no pertinent medical history, drug reaction/allergies, who on 28-FEB-2011 was vaccinated with the second dose of VARIVAX (Merck) (Lot number not provided). In March 2011 (day unknown), the patient developed a rash and nerve pain in her arm with the rash. No lab diagnostics studies were performed. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning her 18 month old daughter who on an unspecified date was vaccinated with a dose VARIVAX (Merck) (Lot #, expire date and route not reported). Pharmacist stated that on an unspecified date after VARIVAX (Merck) vaccination, her daughter broke out in a shingles rash. It was unknown if the patient sought medical attention. At the time of the report, patient's outcome was unknown. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning her son who on an unknown date was vaccinated with a dose of VARIVAX (Merck) (Lot number not provided). The nurse reported that her son received VARIVAX (Merck) "when he was little" and he developed 3-4 chicken pox lesions several days after he received VARIVAX (Merck). At the time of the report, the patient's outcome was unknown. This is one of two reports from the same source. Additional information has been.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 4 year old female with asthma who in June 2010, was vaccinated with the second dose of VARIVAX (Merck) (lot number 665885/1589Y). Concomitant therapy included FLOVENT, VENTOLIN and ZYRTEC. The patient went to the physician's office on 04-MAR-2011 with chickenpox. At the time of reporting, the patient was recovering from chickenpox. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 4 year old male with asthma who on 10-JUL-2010 was vaccinated with the second dose of VARIVAX (Merck) (lot number 665900/1604Y). Concomitant therapy included BENADRYL, albuterol and QVAR. On 08-MAR-2011 the patient experienced chickenpox; and he sought medical attention via doctor's office visit. At the time of report, patient present status was recovering. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a nurse concerning two teenage females who on an unspecified date were vaccinated with their second dose of VARIVAX (Merck) (lot#667820/0757Z). On an unspecified date the patients had redness, pruritus and local site reactions. The patients sought medical attention and were treated with ice pack and comfort measures. On an unspecified, the patients recovered. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Local reaction, Pruritus
Clinical narrative: Information has been received from a License Visiting Nurse (L.V.N.) concerning a teenage female who on an unspecified date was vaccinated with her second dose of VARIVAX (Merck) (lot#666733/0066z). On an unspecified date the patient had redness, pruritus and local site reactions. The patient sought unspecified medical attention and was treated with ice pack and comfort measures. On an unspecified date, the patient recovered. This is one of several reports received from the same source. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Local reaction, Pruritus
Clinical narrative: Information has been received from a nurse concerning a teenage female who on an unspecified date was vaccinated with her second dose of VARIVAX (Merck). On an unspecified date the patient had redness, pruritus and local site reactions. The patient sought unspecified medical attention and was treated with ice pack and comfort measures. On an unspecified date, the patient recovered. This is one of several reports received from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an 8 year old male with no drug allergies and no medical histories who on 20-NOV-2003 was vaccinated with the first dose of VARIVAX (Merck) (therapy route and lot # not provided). On 04-SEP-2007 he was vaccinated with the second dose of VARIVAX (Merck) (therapy route and lot # not provided). There was no concomitant medication. On 07-MAR-2011 the patient presented to the licensed practical nurse's practice with multiple lesions characteristic of chicken pox. The patient's mother stated that the lesions began to appear two days prior to the office visit, on 05-MAR-2011. The patient, who was otherwise "healthy", was started on KEFLEX 500 mg to prevent secondary infection and was being referred to an infectious disease specialist. No lab diagnostics studies were performed. At the time of reporting, the patient's status was recovering. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site urticaria, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning a 11 year old female with no pertinent medical history or drug reactions/allergies who on 07-MAR-2011 (also reported as 08-MAY-2001) was vaccinated SC with 0.5 ml VARIVAX (Merck) (lot # 668602/1273Z, Exp. September 2012). There was no concomitant medication. On 08-MAR-2011 the patient's father called the physician's office to report that the patient had developed a painful, no itchy, "red welt" at the injection site that was the size of a golf ball. The patient was treated with MOTRIN and BENADRYL. On 10-MAR-2011 the patient came to the physician's office and the injection site was noted to be red and warm to touch. The diameter of the red area was 3-4 centimeters. The registered nurse reported that the patient's father reported that the diameter of the red area was growing in size, but that the redness was fading and the pain was less. The patient did not recover from these events at the time of this report. No lab diagnostic studies were performed. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Rash, Varicella post vaccine, Varicella virus test positive
Clinical narrative: Information has been received from an office manager concerning an approximately 48 year old female patient who in "before 2008" on an unspecified date, was vaccinated with one dose of VARIVAX (Merck) (Lot number not reported) at her practice. The office manager stated that the patient now presented to the physician with a rash suspicious of chicken pox. The patient had a blood test for antibodies to varicella zoster virus performed, that showed IgG title positive and IgM title negative. At the time of the report, patient had not recovered. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash generalised, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 24 or 36 months old child female who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) on an unknown site (lot number not reported). The physician reported that the on the same day as the vaccination the patient had fever. The second day, post vaccination the patient's mother called the physician and said her daughter's entire body was covered with a rash that appeared to be chicken pox. The patient's mother brought her to the physician's office on day three and the rash was gone and the patient recovered (date unspecified). Additional information has been requested.